Clinical Oncology
Volume 21, Issue 8 , Pages 610-616 , October 2009

Effect of the UK Postcode Lottery on Survival of Patients with Metastatic Renal Cancer: an Audit of Outcomes in Patients with Metastatic Renal Cancer Suitable for Treatment with Tyrosine Kinase Inhibitors

  • N. James

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    • Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    • ,
  • J. Pascoe

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    • Corresponding Author InformationAuthor for correspondence: N. James, CRUK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Tel: +44-121-414-4097.
    • ,
  • A. Zachariah

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • ,
  • D. Ray

      Affiliations

    • Quality Outcomes Research Unit, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • ,
  • A. Oldroyd

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • ,
  • H. Parry

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • ,
  • H. Benghiat

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • ,
  • M. Karina

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • ,
  • S. Collins

      Affiliations

    • Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    • ,
  • E. Porfiri

      Affiliations

    • Cancer Centre, University Hospitals Birmingham NHS Foundation Trust, Edgbaston, Birmingham B15 2TH, UK
    • Cancer Research UK Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    • Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK

Received 19 October 2008 ,Revised 13 May 2009 ,Accepted 23 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0936-6555(09)00189-7

doi: 10.1016/j.clon.2009.06.007

Clinical Oncology
Volume 21, Issue 8 , Pages 610-616 , October 2009

Article Tools

* Image Usage & Resolution